Patients are expected to enroll in the post-marketing study in the coming weeks, following approval from the Institutional Review Board of West Cancer Center & Research Institute in Germantown, TN CAESAREA, Israel, Aug. 20, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM)...
Hence then, the article about west cancer center receives irb approval to commence icecure s choice study for breast cancer cryoablation was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation )
Also on site :
- Why one highway exploded this summer — and why many more are at risk
- Blueprint Finance Announces Strategic Funding Round to Scale Concrete's Institutional DeFi Infrastructure
- TIER IV collaborates with Renesas to build an open AI-native computing platform for SDVs: Integrating R-Car Gen 5 automotive SoCs with Autoware and reference AI models